Back to Search

DAVID YARDLEY, MD

MD

Cardiovascular Disease Physician

NPI: 1548253560IndividualAccepts Medicare

Specialties, Licenses & Credentials

Cardiovascular Disease PhysicianPrimary

Internal Medicine — Cardiovascular Disease

Code: 207RC0000X

K9202(TX)

CMS Specialties

PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)

Education

LOYOLA UNIVERSITY OF CHICAGO, STRITCH SCHOOL OF MEDICINE

Class of 1980

Research & Publications (20)

Weekly gemcitabine and trastuzumab in the treatment of patients with HER2-overexpressing metastatic breast cancer.
PMID 19661042·Clin Breast Cancer·2009
3-trial
Proactive management of adverse events maintains the clinical benefit of ixabepilone.
PMID 19411315·Oncologist·2009
6-review
Phase II trial of weekly docetaxel, vinorelbine, and trastuzumab in the first-line treatment of patients with HER2-positive metastatic breast cancer.
PMID 19299236·Clin Breast Cancer·2009
3-trial
A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer.
PMID 19294387·Cancer Chemother Pharmacol·2009
3-trial
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.
PMID 19228746·Clin Cancer Res·2009
3-trial
Activity of ixabepilone in patients with metastatic breast cancer with primary resistance to taxanes.
PMID 19073502·Clin Breast Cancer·2008
6-review
A phase II trial of gemcitabine/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer.
PMID 18952556·Clin Breast Cancer·2008
3-trial
A phase II feasibility trial of dose-dense docetaxel followed by doxorubicin/cyclophosphamide as adjuvant or neoadjuvant treatment for women with node-positive or high-risk node-negative breast cancer.
PMID 18650154·Clin Breast Cancer·2008
3-trial
Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.
PMID 17922972·Clin Lung Cancer·2007
3-trial
Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
PMID 17805064·J Thorac Oncol·2007
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
2310 N ED CAREY DR, SUITE 1A
HARLINGEN, TX 78550

Quick Facts

NPI
1548253560
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
46
Publications
20

Are you this provider?

Claim Your Profile